{
  "verifier_model": "tiiuae/falcon-7b-instruct",
  "quantized": true,
  "total_queries_processed": 10,
  "correctly_chosen_by_logprob": 7,
  "accuracy_percentage": 70.0,
  "queries_with_scoring_errors": 0,
  "response_files_used": [
    "Qwen_Qwen2.5-1.5B-Instruct_responses.jsonl",
    "dummy_model_responses.jsonl",
    "Qwen_Qwen2.5-3B-Instruct_responses.jsonl",
    "Qwen_Qwen2.5-7B-Instruct_responses.jsonl"
  ],
  "original_data_file": "/teamspace/studios/this_studio/llm_evaluation/examples/longhealth_semantic_filtering/data/processed/longhealth_cleaned.jsonl",
  "evaluation_details": [
    {
      "id": "patient_01_q0",
      "correct_answer_letter": "D",
      "best_response_by_logprob": {
        "id": "patient_01_q0",
        "generated_text": "D: Vincristine\n\nVincristine is not part of the current treatment regimen for Mrs. Sample's DLBCL. The context clearly states the current treatment regimen which includes:\n\n- Polatuzumab vedotin:",
        "model_name": "Qwen/Qwen2.5-3B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.5816843509674072
      },
      "chosen_letter_by_logprob": "D",
      "is_correct": true,
      "min_avg_nll": 2.5816843509674072
    },
    {
      "id": "patient_01_q1",
      "correct_answer_letter": "D",
      "best_response_by_logprob": {
        "id": "patient_01_q1",
        "generated_text": "D: She has 3-vessel CHD. is NOT accurate based on the provided information. The text for option D: She has 3-vessel CHD. is NOT accurate based on the provided information. : She has 2-v",
        "model_name": "Qwen/Qwen2.5-3B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.3577163219451904
      },
      "chosen_letter_by_logprob": "D",
      "is_correct": true,
      "min_avg_nll": 2.3577163219451904
    },
    {
      "id": "patient_01_q2",
      "correct_answer_letter": "A",
      "best_response_by_logprob": {
        "id": "patient_01_q2",
        "generated_text": "2: Multiple sclerosis\n\nThe patient diagnosed with multiple sclerosis is a 42-year-old woman with a history of recurrent, relapsing episodes. She presents with a variety of symptoms including a \"mass in the neck,\" numbness in both upper",
        "model_name": "Qwen/Qwen2.5-1.5B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.362607002258301
      },
      "chosen_letter_by_logprob": null,
      "is_correct": false,
      "min_avg_nll": 2.362607002258301
    },
    {
      "id": "patient_01_q3",
      "correct_answer_letter": "B",
      "best_response_by_logprob": {
        "id": "patient_01_q3",
        "generated_text": "B: Fingolimod 0.5mg, 1 capsule at bedtime, Note: Take a break as directed\nAnswer: B: Fingolimod 0.5mg, 1 capsule at bedtime, Note:",
        "model_name": "Qwen/Qwen2.5-7B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 1.8291569948196411
      },
      "chosen_letter_by_logprob": "B",
      "is_correct": true,
      "min_avg_nll": 1.8291569948196411
    },
    {
      "id": "patient_01_q4",
      "correct_answer_letter": "D",
      "best_response_by_logprob": {
        "id": "patient_01_q4",
        "generated_text": "D: 6 cycles of R-Pola-CHP\n\nThe oncology board recommends six cycles of the R-Pola-CHP regimen for Mrs. Sample, indicating the continuation of the current treatment plan without further modifications. This recommendation is based",
        "model_name": "Qwen/Qwen2.5-1.5B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.562131881713867
      },
      "chosen_letter_by_logprob": "D",
      "is_correct": true,
      "min_avg_nll": 2.562131881713867
    },
    {
      "id": "patient_01_q5",
      "correct_answer_letter": "C",
      "best_response_by_logprob": {
        "id": "patient_01_q5",
        "generated_text": "C: Thoracic vertebra 10\nBased on the context provided, the metastasis that was surgically addressed is located at the thoracic vertebra 10. The relevant text from the initial update is as follows:\n\n**Pathology",
        "model_name": "Qwen/Qwen2.5-7B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.727684736251831
      },
      "chosen_letter_by_logprob": "C",
      "is_correct": true,
      "min_avg_nll": 2.727684736251831
    },
    {
      "id": "patient_01_q6",
      "correct_answer_letter": "A",
      "best_response_by_logprob": {
        "id": "patient_01_q6",
        "generated_text": "01/09/2017, a multi-slice helical CT of the chest, abdomen, and pelvis was performed during the venous phase of contrast enhancement. Additional oral contrast was given using Gastrografin (d",
        "model_name": "Qwen/Qwen2.5-1.5B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.645080804824829
      },
      "chosen_letter_by_logprob": null,
      "is_correct": false,
      "min_avg_nll": 2.645080804824829
    },
    {
      "id": "patient_01_q7",
      "correct_answer_letter": "B",
      "best_response_by_logprob": {
        "id": "patient_01_q7",
        "generated_text": "B: MR Spine plain + post-contrast from 12/20/2016, MR Head 3D unenhanced + contrast from 12/19/2016, CT Thoracic Sp",
        "model_name": "Qwen/Qwen2.5-7B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 1.4498753547668457
      },
      "chosen_letter_by_logprob": "B",
      "is_correct": true,
      "min_avg_nll": 1.4498753547668457
    },
    {
      "id": "patient_01_q8",
      "correct_answer_letter": "E",
      "best_response_by_logprob": {
        "id": "patient_01_q8",
        "generated_text": "**B: The patient started taking Pregabalin 75 mg, 1-0-1-0**.\n\nAnswer: **B: The patient started taking Pregabalin 75 mg, 1-0-1",
        "model_name": "Qwen/Qwen2.5-7B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 1.8324644565582275
      },
      "chosen_letter_by_logprob": null,
      "is_correct": false,
      "min_avg_nll": 1.8324644565582275
    },
    {
      "id": "patient_01_q9",
      "correct_answer_letter": "B",
      "best_response_by_logprob": {
        "id": "patient_01_q9",
        "generated_text": "B: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.\n: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake. The dosage of",
        "model_name": "Qwen/Qwen2.5-3B-Instruct",
        "generation_params": {
          "temperature": 0.7,
          "max_new_tokens": 50,
          "top_p": 0.9,
          "index": 0
        },
        "verifier_avg_nll": 2.2904531955718994
      },
      "chosen_letter_by_logprob": "B",
      "is_correct": true,
      "min_avg_nll": 2.2904531955718994
    }
  ]
}